Clinical Trial Update: The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease [Phase 3]

View source ↗

Summary

This document reports the completion status of the Phase 3 CLARICOR trial evaluating whether clarithromycin affects mortality and morbidity in patients with isc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Biaxin (clarithromycin)

Snippet

Sponsor: Copenhagen Trial Unit, Center for Clinical Intervention Research | Conditions: Heart Disease, Cardiovascular Disease | Phase 3 | Status: COMPLETED